Congratulations to the BlueRock team on positive Phase 1 results. Incredibly happy to see so many years of hard work advancing with such promise for patients. #parkinsonsdisease#regenerativemedicine https://t.co/kh72KSNeLF
Data is the deliverable. "Making data a core deliverable, rather than an afterthought, means getting the right people in the room, collecting the right information, and connecting seemingly disparate data points through a well-structured data backbone." https://t.co/g6iLCmvEBo
One more step towards making gene therapies more accessible and sustainable no matter the size of the patient population.#FNIH. #BGTC https://t.co/pxUuwuCsix
Today, in recognition of International Women's Day, I would like to give a shout out to some of the amazing colleagues at Danaher who have inspired me in this very rewarding journey I have been on since joining this incredible company 2 years ago. Vaness…https://t.co/LlfP0wlGyX
It is a great pleasure to announce our latest Beacon for cell therapy innovation at the University of Pennsylvania with Carl June's Center for Cellular Immunotherapies. Fantastic to be working with Drs. Megan M. Davis, Ph.D., Jose…https://t.co/ddVOsUAUgU https://t.co/GwZ8vJp9wn
February 28th is #RareDiseaseDay. With all our advancements in Cell & Gene Therapy, we are still very much "Not Good Enough". FNIH, with its partners including Danaher, are working to change that. #RDDNIH https://t.co/zSQPhj5dCr
Congratulations to Sadik Kassim for being named a top healthcare tech leader of Massachusetts. I feel privileged to work with you. https://t.co/tjJalk3uXI
Insights from Geoff MacKay, one of the true visionaries on how to sustainably translate cell and gene therapies. What will 2023 bring? https://t.co/9O5HGPf59y